It has been reported that viral sequestration into the liver and subsequent infection of the hepatocytes following systemic administration of serotype 5 adenoviruses can be reduced by introducing mutations into the Ad5 hexon protein that abolish binding of the viral capsid to the blood coagulation factor X (FX) [43], [44]. The gene discussed is F10; the disease is infection.